杭州景业智能科技股份有限公司 一、2024年年审会计师事务所基本情况 （一）会计师事务所基本情况 天健所成立于2011年7月，注册地址为浙江省杭州市西湖区灵隐街道西溪路128 号，首席合伙人为钟建国先生，拥有财政部颁发的会计师事务所执业证书。截至 2024年12月31日，天健所合伙人数量为241人，注册会计师2,356人，其中签署过证 券服务业务审计报告的注册会计师904人。天健所2023年（经审计）业务收入为人 民币34.83亿元，其中审计业务收入人民币30.99亿元；证券业务收入18.40亿元。 2024年度上市公司（含A、B股）审计客户共计707家，收费总额人民币7.20亿元。 这些上市公司主要行业涉及制造业，信息传输、软件和信息技术服务业，批发和零 售业，房地产业，建筑业，电力、热力、燃气及水生产和供应业，金融业，交通运 输、仓储和邮政业等。本公司同行业上市公司审计客户544家。 （二）聘任会计师事务所履行的程序 公司第二届董事会审计委员会第三次会议、第二届董事会第四次会议及2023年 年度股东大会审议通过了《关于续聘会计师事务所的议案》，同意聘任天健所为公 司2024年度审计机构。 二、审计委员会对 ...

证券代码：688290 证券简称：景业智能 公告编号：2025-024 杭州景业智能科技股份有限公司 关于使用暂时闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州景业智能科技股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日 分别召开的第二届董事会第十三次会议和第二届监事会第九次会议审议通过了 《关于使用暂时闲置募集资金进行现金管理的议案》，同意公司使用不超过人民 币 30,000 万元的闲置募集资金进行现金管理，使用期限自董事会审议通过之日 起 12 个月内有效。在不超过上述额度及决议有效期内，资金可循环滚动使用， 并于到期日前归还至募集资金专项账户。在授权额度内，董事会授权公司董事长 或董事长授权人员在上述额度范围内行使投资决策权并签署相关合同文件，具体 事项由公司财务管理部负责组织实施。 监事会发表了明确的同意意见，中信证券股份有限公司对本事项出具了明确 的核查意见。 一、 募集资金基本情况 （一）2022 年首次公开发行股票实际募集资金情况 根据中国证券监督管理委 ...

证券代码：688290 证券简称：景业智能 公告编号：2025-030 杭州景业智能科技股份有限公司 关于修改《公司章程》及部分管理制度的公告 为进一步规范公司股东会议事行为，根据《公司法》《上市公司章程指引》 《上市公司股东会规则》等相关法律法规、规范性文件的最新规定，并结合公司 实际情况，公司重新制定了《股东会议事规则》。 本次重新制定《股东会议事规则》事项尚需提交公司 2024 年年度股东大会 审议通过后方可实施。具体内容详见同日刊登在上海证券交易所网站 （www.sse.com.cn）的《杭州景业智能科技股份有限公司股东会议事规则》。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州景业智能科技股份有限公司(以下简称"公司")于 2025 年 4 月 17 日召 开第二届董事会第十三次会议，审议通过了《关于修改<公司章程>并办理工商 变更登记的议案》《关于修改<股东大会议事规则>的议案》，具体情况如下： 为进一步改善和优化公司治理结构，完善公司治理水平，根据《公司法》《上 市公司章程指引》等法律、法规、规范性文 ...

杭州景业智能科技股份有限公司 为积极响应上海证券交易所《关于开展沪市公司"提质增效重回报"专项行动 的倡议》，贯彻落实国务院《关于进一步提高上市公司质量的意见》要求，大力 提高上市公司质量，保障和维护投资者合法权益，杭州景业智能科技股份有限公 司（以下简称"公司"）于2024年4月23日发布了《公司2024年度"提质增效重回报" 行动方案》，并按时发布了半年度评估报告。2024年度，公司积极落实行动方案， 持续聚焦主营业务、提升创新能力、加大投资者回报、完善公司治理。为延续 2024年度行动方案之成果，进一步提高公司质量，助力信心提振、资本市场稳定 和经济高质量发展，公司制定了《公司2025年度"提质增效重回报"行动方案》， 并对2024年度"提质增效重回报"行动方案进行年度评估。具体情况如下： 一、深化产业生态布局，构建多维增长矩阵 公司主要从事特种机器人及智能装备系统的研发、生产及销售，主要产品包括 特种机器人、核工业智能装备系统、非核专用智能装备系统等，产品主要应用于核 工业、国防军工、医药大健康等领域。2024年，公司实现营业收入2.76亿元（同比 +7.94%），归母净利润3,760.00万元（同比 ...

中信证券股份有限公司（以下简称"中信证券""保荐人"）作为杭州景业 智能科技股份有限公司（以下简称"景业智能""公司"）首次公开发行股票并 在科创板上市、以简易程序向特定对象发行人民币普通股（A 股）股票的保荐人， 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》 中信证券股份有限公司 关于杭州景业智能科技股份有限公司 2024 年度募集资金存放与实际使用情况的专项核查报告 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等法律法 规的有关规定，对景业智能 2024 年度募集资金存放与实际使用情况进行了审慎 核查，核查情况如下： 一、募集资金基本情况 （一）2022 年首次公开发行股票募集资金 1、募集资金金额、资金到位时间 根据中国证券监督管理委员会《关于同意杭州景业智能科技股份有限公司首 次公开发行股票注册的批复》（证监许可〔2022〕459 号），公司向社会公开发 行人民币普通股（A 股）股票 2,060 万股，每股发行价格为 33.89 元（人民币， 下同），募集资金总额为 69,813.40 万元，扣除发行费用 7,784.65 万元，公司本 次募集资金净额 ...

证券代码：688290 证券简称：景业智能 公告编号：2025-031 杭州景业智能科技股份有限公司 关于召开 2024 年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024 年年度股东大会 召开日期时间：2025 年 5 月 8 日 13 点 30 分 召开地点：浙江省杭州市滨江区乳泉路 925 号杭州景业智能科技园会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2025 年 5 月 8 日 至 2025 年 5 月 8 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联 股东大会召开日期：2025年5月8日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式 ...

证券代码：688290 证券简称：景业智能 公告编号：2025-021 杭州景业智能科技股份有限公司 第二届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 杭州景业智能科技股份有限公司（以下简称"公司"）第二届监事会第九次会 议于 2025 年 4 月 17 日在公司会议室召开。本次会议应到监事 3 人，实到监事 3 人，会议由监事会主席华龙先生主持。会议的召集和召开程序符合《公司法》《公 司章程》等相关规定，会议形成的决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于 2024 年年度报告及其摘要的议案》 监事会认为：公司 2024 年年度报告及其摘要能够严格按照《上海证券交易 所科创板股票上市规则》《公开发行证券的公司信息披露内容与格式准则第 2 号 ——年度报告的内容与格式》及其他相关文件的要求编制，内容和格式符合要求； 公司 2024 年年度报告及其摘要履行了相应的审议、审批程序，公司董事、监事、 高级管理人员签署了书面确认意见，符合《公司法》《证券法》 ...

证券代码：688290 证券简称：景业智能 公告编号：2025-020 杭州景业智能科技股份有限公司 第二届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 杭州景业智能科技股份有限公司（以下简称"公司"）第二届董事会第十三 次会议于 2025 年 4 月 17 日以现场结合通讯方式召开。本次会议应到董事 9 人， 实到董事 9 人，会议由董事长来建良先生主持。会议的召集和召开程序符合《公 司法》《公司章程》等相关规定，会议形成的决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于 2024 年年度报告及摘要的议案》 董事会认为《公司 2024 年年度报告》及其摘要的编制和审核程序符合相关 法律法规及《公司章程》的相关规定，能够公允地反映公司报告期内的财务状况 和经营成果。董事会及全体董事保证公司 2024 年年度报告及其摘要所披露的信 息真实、准确、完整，所载资料不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见同日刊登在上海证券交易所网站（www.sse ...

Financial Performance - The net profit attributable to shareholders for the year 2024 is CNY 37.6 million, with a distributable profit of CNY 231.36 million as of December 31, 2024[7]. - The proposed cash dividend for 2024 is CNY 0.65 per 10 shares, totaling CNY 6.5881 million, which represents 110.78% of the net profit attributable to shareholders[7]. - The mid-year cash dividend of CNY 0.50 per 10 shares has already been distributed, amounting to CNY 5.0678 million[7]. - The total amount for cash dividends and share repurchases in 2024 is CNY 41.6524 million, which is 110.78% of the net profit attributable to shareholders[7]. - The company's operating revenue for 2024 reached ¥275,725,673.21, representing a year-over-year increase of 7.94% compared to ¥255,442,358.56 in 2023[24]. - The net profit attributable to shareholders for 2024 was ¥37,600,037.13, an increase of 8.40% from ¥34,686,780.54 in 2023[24]. - The cash flow from operating activities for 2024 was ¥29,195,921.49, showing a significant increase of 30.72% compared to ¥22,334,951.17 in 2023[24]. - The total assets as of the end of 2024 were ¥1,568,158,790.23, a slight decrease of 0.22% from ¥1,571,587,749.46 at the end of 2023[24]. - The basic earnings per share for 2024 was ¥0.37, reflecting a 5.71% increase from ¥0.35 in 2023[25]. - The weighted average return on equity for 2024 was 3.00%, a decrease of 0.06 percentage points from 3.06% in 2023[25]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥17,178,915.98, up 5.67% from ¥16,257,710.51 in 2023[24]. Risk Management - The company has not identified any significant risks that could materially affect its operations during the reporting period[4]. - The company has confirmed that there are no non-operational fund occupations by controlling shareholders or related parties[11]. - The company faces risks related to core technology talent loss, which could adversely affect product competitiveness and innovation capabilities[104]. - The company faces risks related to potential adverse changes in nuclear industry policies and macroeconomic conditions, which could impact future growth[115][116]. - The company may experience a decline in gross profit margin due to increased competition and potential price concessions to attract new customers[113]. Research and Development - The company reported a research and development expense ratio of 11.03% of operating revenue for the reporting period[27]. - The company achieved a total R&D investment of ¥30,416,777.27, a decrease of 25.06% compared to the previous year[88]. - R&D investment accounted for 11.03% of total revenue, down by 4.86 percentage points from 15.89% in the previous year[88]. - The company holds a total of 320 intellectual property rights, including 107 invention patents and 140 utility model patents[86]. - The company has established a national-level postdoctoral research station to strengthen its R&D capabilities and maintain technological innovation[97]. - The company is focusing on autonomous R&D and technological innovation to meet the demands of the nuclear and military industries[97]. Market Strategy and Growth - The company plans to continue expanding its market presence and invest in new technologies and products to drive future growth[1]. - The company aims to accelerate operations in the new product division in 2025 to further enhance market competitiveness and resource integration capabilities[38]. - The company is actively exploring new market segments to tap into additional revenue streams and enhance overall profitability[177]. - The company is leveraging policy support, including tax incentives and special funds, to drive investment in high-value-added areas of technology[152]. - The company aims to enhance collaborative efficiency in logistics through the implementation of swarm intelligence technologies[153]. Corporate Governance - The company has established a robust internal control system and governance structure, enhancing operational compliance and protecting shareholder rights[170]. - The company has implemented a strict insider information management system, with no violations reported during the reporting period[170]. - The company has held 4 shareholder meetings in 2024, ensuring compliance with legal regulations and protecting the rights of all shareholders, especially minority shareholders[168]. - The second board of directors convened 6 meetings during the reporting period, with a composition that meets legal requirements, including 3 independent directors[169]. - The company has not reported any significant changes in business independence or competition with controlling shareholders[171]. Operational Efficiency - The company is focused on improving its public image through compliance in capital operations, mergers, and investor relations[165]. - The company is committed to aligning its remuneration practices with industry standards and its operational performance[183]. - The company aims to improve operational efficiency through technological advancements and process optimization[177]. - The company reported a 5% decrease in operational costs due to improved efficiency measures[178]. - The company has established a systematic employee training mechanism, including various training programs for new hires and skill enhancement[199]. Product Development and Innovation - The company has developed a new heavy-duty hydraulic robotic arm prototype to meet specific nuclear facility decommissioning needs, showcasing its innovation in product development[50]. - The company has completed the development of five core components for its explosion-proof AGV products, achieving explosion-proof certification for these components[52]. - The company is developing a radioactive waste intelligent treatment system, which is currently in the design phase, targeting the nuclear industry[91]. - The company is actively involved in the research and development of high-temperature materials and radiation-resistant structures to expand application boundaries in various industries[153]. - The company aims to create a comprehensive customer value system through a lifecycle approach to research, delivery, and operation[158].

Financial Performance - The company's operating revenue for Q1 2025 was ¥21,505,229.07, a decrease of 7.54% compared to ¥23,259,702.77 in the same period last year[4] - The net profit attributable to shareholders was -¥9,903,369.14, an improvement of 11.37% from -¥11,174,381.18 year-on-year[4] - The net cash flow from operating activities was -¥39,634,591.51, representing a decline of 24.82% compared to -¥31,753,949.04 in the previous year[4] - Total revenue for Q1 2025 was CNY 21,505,229.07, a decrease of 7.6% compared to CNY 23,259,702.77 in Q1 2024[15] - Net loss for Q1 2025 was CNY 10,239,770.03, compared to a net loss of CNY 11,655,832.27 in Q1 2024, showing an improvement of 12.1%[16] - Total comprehensive income for Q1 2025 was a loss of ¥10,239,770.03, compared to a loss of ¥11,655,832.27 in Q1 2024, indicating a reduction in losses of about 12.1%[17] Cash Flow - Cash inflow from investment activities in Q1 2025 was ¥464,400,506.85, significantly higher than ¥233,288,632.78 in Q1 2024, marking an increase of approximately 98.7%[21] - Cash outflow from investment activities for Q1 2025 was ¥444,304,985.19, compared to ¥117,948,189.23 in Q1 2024, indicating a substantial increase of about 276.5%[21] - The net cash flow from investment activities for Q1 2025 was ¥20,095,521.66, down from ¥115,340,443.55 in Q1 2024, showing a decline of approximately 82.6%[21] - The net cash flow from financing activities for Q1 2025 was ¥3,428,603.01, compared to a negative cash flow of ¥4,856,026.02 in Q1 2024, indicating a turnaround[21] - The ending cash and cash equivalents balance for Q1 2025 was ¥69,410,015.74, down from ¥289,967,601.65 in Q1 2024, reflecting a decrease of approximately 76.0%[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,567,758,195.08, a minor decrease of 0.03% from ¥1,568,158,790.23 at the end of the previous year[5] - Total liabilities increased to CNY 292,329,988.80 as of March 31, 2025, compared to CNY 283,808,647.90 as of December 31, 2024, marking a rise of 3.5%[13] - Non-current assets totaled CNY 662,332,557.65 as of March 31, 2025, up from CNY 612,085,523.74 as of December 31, 2024, reflecting an increase of 8.2%[12] Research and Development - Research and development expenses totaled ¥7,941,170.31, accounting for 36.93% of operating revenue, a slight decrease of 0.53 percentage points from the previous year[5] - Research and development expenses for Q1 2025 were CNY 7,941,170.31, a decrease from CNY 8,712,192.92 in Q1 2024, indicating a reduction of 8.8%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period was 6,227[8] - The largest shareholder, Hangzhou Xingzhiyuan Holdings Co., Ltd., held 28,661,917 shares, representing 28.05% of the total shares[8] Government Subsidies and Gains - The company received government subsidies amounting to ¥209,628.62, which are closely related to its normal business operations[6] - The company reported a total of ¥3,562,357.51 in non-recurring gains and losses for the period[6] - The company reported an investment income of CNY 7,069,215.29 in Q1 2025, significantly higher than CNY 1,180,410.73 in Q1 2024, representing a growth of 498.5%[16] Return on Assets - The weighted average return on net assets was -0.78%, an improvement from -0.90% in the same period last year[5]